Downregulation of neuregulin 1-ErbB4 signaling and antidepressant properties of ketamine: ErbB4 expressing pyramidal neurons may play a role.
We comment on a recent paper of Wang et al. (J Mol Neurosci, 2014), who have shown that ketamine reduces neuregulin1-ErbB4 signaling in interneurons.